Sponsors & Exhibitors
At Kiadis Pharma we are committed to developing innovative cell-based immunotherapies for patients with life-threatening diseases. We are a leader in this field, with complementary investigational T-cell and NK-cell platforms focused initially on hematopoietic stem cell transplants. We leverage the natural strengths of humanity and our collective immune systems to source the best cells for life. Our uncompromising approach to serve patients, their families and caregivers aims to minimize harm and maximize help – delivering personalized treatments for every single patient to offer hope, reduce suffering and provide new life.
1105 BP Amsterdam, The Netherlands
T +31 (0)20 240 52 50
Celgene is a global biopharmaceutical company. The Celgene Corporation was founded in 1986 in New Jersey, USA. The company focuses on research, development and commercialization of innovative therapies for the treatment of hematological, oncological and severe immune and inflammatory diseases. Celgene invests more than 30 percent of its annual revenue in research and development activities to help patients live longer, better and more productive lives through new treatment options. For more information, please visit the Celgene GmbH website at www.celgene.de.
81829 München (Germany)
Telefon: +49 89 4 51 51 9 - 010
Telefax: +49 89 4 51 51 9 - 019
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California, USA.
Kite, a Gilead Company, is a biopharmaceutical company based in Santa Monica, California, USA. Kite is engaged in the development of innovative cancer immunotherapies. The company is focused on chimeric antigen receptor and T cell receptor engineered cell therapies.
For more information, please visit www.gilead.com.
Kite Pharma EU B.V.
Science Park 408
1098 XH Amsterdam
Gilead Sciences GmbH
82152 Martinsried/ München
Tel.: 089 899 8900
Fax: 089 899 89090
Mallinckrodt Pharmaceuticals (Therakos (UK) Ltd)
Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Our Specialty Brands segment includes branded medicines and the Specialty Generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing. Mallinckrodt is the only provider of integrated systems for the delivery of Extracorporeal Photopheresis (ECP). To learn more about this product, visit www.therakos.co.uk.
Mallinckrodt Pharmaceuticals (Therakos (UK) Ltd)
3 Lotus Park, The Causeway, Staines-upon-Thames, Surrey, TW18 3AG, UK
+44 (0) 1784 636 700
MSD – Merck & Co., Inc., in the USA and Canada, with headquarters in Kenilworth, NJ, USA – is a leading global healthcare company. MSD's core business is the discovery, development, production and distribution of prescription medicines, vaccines, biologic therapies and animal health products. In 2017, the company generated sales of approximately 40.1 billion US dollars with approximately 69,000
employees in more than 140 countries. The company has its German headquarters in Haar near Munich.
Tel: 0800 673 673 673
Fax: 0800 673 673 329
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105 000 people of nearly 140 nationalities work at Novartis around the world. Find out more at www.novartis.com.
Novartis Pharma GmbH
Phone +49 911 273-0
Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. We make medicines and vaccines that help people when they are sick and prevent them from getting sick in the first place, as well as some of the world’s best-known consumer healthcare brands. Every day, our colleagues work in developed and emerging markets to treat, cure and eradicate life-threatening conditions and challenge some of the most feared diseases of our time. Pfizer also collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.
Pfizer Pharma GmbH
Linkstrasse 10, 10785 Berlin
Tel: +49 (0)30 550055-01
Fax +49 (0)30 550054-9999
Sanofi Genzyme, the Specialty Care Business Unit of Sanofi, focuses on Rare Diseases, Multiple Sclerosis, Oncology, Immunology and Rare Blood Disorders.
We help people with debilitating and complex conditions that are often difficult to diagnose and treat.
Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities.
We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.
Jazz Pharmaceuticals plc, a global biopharmaceutical company, is dedicated to developing life-changing medicines for people with limited or no options, so they can live their lives more fully and redefine what is possible. As a leader in sleep medicine in the U.S. and with a growing haematology/oncology portfolio, Jazz has a diverse portfolio of products and product candidates in development, and is focused on transforming biopharmaceutical discoveries into novel medicines.
For more information, please visit www.jazzpharmaceuticals.com or contact
General Manager Germany & Austria
Jazz Pharmaceuticals Germany GmbH
Mobil: +49 160 4730308
Office: +49 89 41109668
medac Gesellschaft für klinische Spezialpräparate mbH
medac is a privately held German pharmaceutical company located in Wedel, Tornesch and Hamburg. Medicinal products from medac support doctors and patients throughout the world in overcoming acute and chronic diseases in the indication areas of oncology, haematology, urology and autoimmune disorders. In addition, medac develops and markets special diagnostic test systems. Since 1970 medac has been committed to unifying therapeutic and diagnostic areas under one roof.
You can find further information about the company and its products at www.medac.de.
Neovii Pharmaceuticals AG
Neovii is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders.
Neovii was founded in 2013 by the acquisition of Fresenius Biotech inheriting more than three decades of experience in speciality pharmaceuticals.
Neovii’s global headquarters are located in Rapperswil, Switzerland, its U.S headquarters are in Waltham, MA, and its biologics manufacturing site and German operations are located in Gräfelfing, Germany. Neovii employs approx. 150 employees and has presence in nearly 60 countries worldwide.
Phone (with country code): +41 55 210 0500
RIEMSER Pharma GmbH
The history of RIEMSER is closely connected to the Friedrich-Löffler-Institut on the island Riems. Although its origins are in veterinary medicines, in recent years in particular RIEMSER has increasingly established itself as a strong player in the field of human medicine. By selling our veterinary medicines business and by outsourcing our production, we were able to focus our efforts on our strengths in marketing and distribution. Since 2009, RIEMSER has been pursuing the goal of expanding its product range of medicines for the treatment of serious diseases in the fields of oncology/haematology, infectiology and neurology. As part of its clear growth strategy, RIEMSER is constantly searching for innovative products or interesting partnerships. In 2014 and 2015, the subsidiaries Keocyt domiciled in France and Intrapharm domiciled in England joined the RIEMSER group. Our focus on specific therapeutic fields and on Europe makes us a powerful marketing and distribution partner.
Greifswald – Insel Riems
An der Wiek 7
17493 Greifswald – Insel Riems
bluebird bio, Inc.
bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., headquarters, we’re developing gene therapies for severe genetic diseases and cancer, with the goal that people facing potentially fatal conditions with limited treatment options can live their lives fully. Beyond our labs, we’re working to positively disrupt the healthcare system to create access, transparency and education so that gene therapy can become available to all those who can benefit.
bluebird bio is a human company powered by human stories. We’re putting our care and expertise to work across a spectrum of disorders by researching cerebral adrenoleukodystrophy, sickle cell disease, transfusion-dependent β-thalassemia and multiple myeloma using three gene therapy technologies: gene addition, cell therapy and (megaTAL-enabled) gene editing.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
CellGenix is a leading global supplier of high-quality reagents and tools for cell and gene therapy and regenerative medicine applications. As the first company to obtain a GMP manufacturing authorization for cell processing in Europe, we have 25 years of expertise in GMP manufacturing and development of cell therapy products.
We offer a comprehensive product portfolio in combination with expert regulatory and technical support to ensure a seamless transition from research to commercialization. Our products combine a maximum of quality and safety due to the state-of-the-art production, stringent in-house quality control and comprehensive documentation.
For more information, visit cellgenix.com.
EUROCEPT INTERNATIONAL BV
Eurocept International BV is part of the Eurocept Group, a Dutch group of companies active in the Healthcare industry. Eurocept International BV has over the past few years built an interesting portfolio of vital hospital products.
Eurocept had a clear mission: to simplify the relationship between physicians and patients by offering products and services that answer to pharmaceutical, technology and nursing needs in medical care.
Eurocept aims to achieve this mission by offering a unique combination of pharmaceuticals, homecare, medical technology and distribution in the therapeutic areas of anesthesia, oncology, pediatry, psychiatry, immunology and urology.
Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to meet serious unmet medical needs in in oncology and inflammation and autoimmunity. Incyte is committed to the rigorous pursuit of R&D excellence to improve the lives of patients, make a difference in health care, and build sustainable value.
The Company strives to discover and develop first-in-class and best-in-class medicines—advancing a diverse portfolio of large and small molecules.
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. Used by scientists and clinicians around the world, our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, and cell culture. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Today, Miltenyi Biotec has 2,500 employees in 28 countries – all dedicated to helping researchers and clinicians make a greater impact on science and health.
Miltenyi Biotec GmbH
51429 Bergisch Gladbach
Telefon :+49 2204 8306-0
Successful Consulting in Life-Science Industry for more than 20 years …
We are specialists in personnel consultation in the academic sector – in biotechnology, in pharmaceutical, medical and CRO industry.
We count globally leading and medium-sized enterprises as well as some German universities among our customers.
All our consultants have many years of professional experience, we are able to render an excellent service and highest ethical standards both to our customers and applicants.
The combination of economic and pharmaceutical expertise is the basis of our management consulting and thus the benefit of our customers in healthcare and pharmaceutical companies.
Due to the very good interlinking with recognized academies and trainers, we can offer our clients a comprehensive training portfolio in the files of the pharmaceutical industry and clinical research.
Omeros is a biopharmaceutical company committed to discovering, developing, and commercializing first-in-class small molecule and antibody therapeutics across a diverse range of disorders for orphan and large-market indications. In partnership with physicians, regulators, and patients and their families, Omeros is focused on developing the most effective and safe therapeutics in serious diseases and disorders to improve or save the lives of patients who are suffering.
Together with its marketed ophthalmic drug OMIDRIA®, Omeros’ pipeline is led by narsoplimab (OMS721). Narsoplimab is a fully human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), the effector enzyme of the lectin pathway of the complement system. Phase 3 clinical programs with narsoplimab are ongoing in hematopoietic stem cell-associated thrombotic microangiopathy, IgA nephropathy, and atypical hemolytic-uremic syndrome. Omeros’ pipeline includes additional large and small molecule complement inhibitors that are in development, as well as compounds being developed for addictions and other disorders of the central nervous system and immune-related diseases, including cancers.
Ontime Onboard Courier GmbH
Since 2003 we have provided more than 25.000 accompanied HSC transports for many acknowledged Registries, Collection
Centers and Transplant Centers worldwide. We offer services from and to every location on the globe, mainly delivering on
the day of donation. Our goal is to create the best and fastest connection for each individual transport in order to
contribute to the recovery of affected patients around the world.
Our experience on all 6 continents serving more than 400 transplant centers guarantees the quality you are looking for.
24/7/365 – multi lingual staff – online tracking – we cover all your needs.
email@example.com or +49-89-357373-20 – contact us to find out more!
Prompt response of our well-trained team concerning your request enables quick decisions on your part.